(2R)-2((3-Cyano-2-(4-(3-methylpyridin-2-yl)phenyl)-1,7-naphthyridin-4-yl)amino)butanamide

ID: ALA5281763

Max Phase: Preclinical

Molecular Formula: C25H22N6O

Molecular Weight: 422.49

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3ncccc3C)cc2)nc2cnccc12)C(N)=O

Standard InChI:  InChI=1S/C25H22N6O/c1-3-20(25(27)32)30-24-18-10-12-28-14-21(18)31-23(19(24)13-26)17-8-6-16(7-9-17)22-15(2)5-4-11-29-22/h4-12,14,20H,3H2,1-2H3,(H2,27,32)(H,30,31)/t20-/m1/s1

Standard InChI Key:  FHWBYMRBWPGYDL-HXUWFJFHSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   22.3031   -5.6602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.0190   -5.2470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0162   -4.4171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3013   -4.0082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5887   -5.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5910   -4.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8789   -4.0098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1639   -4.4209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1655   -5.2491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8784   -5.6581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7263   -4.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4388   -3.5860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7301   -5.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7301   -6.4829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4439   -6.8939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1583   -6.4806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1542   -5.6519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4399   -5.2446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2978   -3.1837    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5820   -2.7745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5784   -1.9502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8627   -1.5410    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2907   -1.5348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8698   -3.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8703   -6.8899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8714   -7.7155    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5857   -8.1256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2995   -7.7112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2945   -6.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5796   -6.4761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1540   -2.7807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5749   -5.6517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  2  0
 11 12  3  0
  3 11  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  2 13  1  0
  4 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 20 24  1  6
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 16 25  1  0
 24 31  1  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5281763

    ---

Associated Targets(Human)

PIP4K2A Tbio Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha (1501 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.49Molecular Weight (Monoisotopic): 422.1855AlogP: 4.21#Rotatable Bonds: 6
Polar Surface Area: 117.58Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.83CX LogP: 3.37CX LogD: 3.37
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.48Np Likeness Score: -0.86

References

1. Wortmann L, Bräuer N, Holton SJ, Irlbacher H, Weiske J, Lechner C, Meier R, Karén J, Siöberg CB, Pütter V, Christ CD, Ter Laak A, Lienau P, Lesche R, Nicke B, Cheung SH, Bauser M, Haegebarth A, von Nussbaum F, Mumberg D, Lemos C..  (2021)  Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.,  64  (21.0): [PMID:34699202] [10.1021/acs.jmedchem.1c01245]

Source